FDA – Comments Submitted to FDA on Risk Evaluation and Mitigation Strategies: Modifications and Revisions; Guidance for Industry

Comments Submitted to FDA on Risk Evaluation and Mitigation Strategies: Modifications and Revisions; Guidance for Industry. (Docket Number: FDA-2014-D-1747-0001).

Click here to read the comments.